Literature DB >> 7490200

Infertility-epidemiology, aetiology and effective management.

A Templeton1.   

Abstract

Current epidemiological evidence suggests that 15% of couples will experience infertility and in half this number the problem will remain unresolved. Background prevalence rates now appear to be reasonably stable, but there is evidence of an increase in the rate of referrals for medical help. Rates of secondary infertility are higher in the population than represented by clinic referrals. The distribution of the main diagnostic groups is as follows: Male 25%; Ovulation 25%; Tubal 20%; Unexplained 25%; and Endometriosis 5%. Effective management in the male includes donor insemination and assisted reproduction (including intra-cytoplasmic sperm injection). Drugs are ineffective for idiopathic oligozoospermia, while the role of varicocele ligation is uncertain, but marginal at best. Ovulation problems can be treated with a high degree of success, except in cases of clomiphene resistant polycystic ovarian disease. However there are continuing concerns over multiple pregnancy rates and future research is needed to clarify the additional risks, if any, of ovarian carcinoma. Surgical correction of tubal abnormalities should be left to specialised units, where audit indicates that the results can match those achieved by assisted reproduction. There is no evidence that the medical (drug) management of endometriosis improves fertility, although surgery for moderate and severe disease can still be considered. However the results should be compared with those achieved by assisted reproduction. Superovulation and intra-uterine insemination appears to be an effective treatment for certain cases of mild male factor infertility, mild endometriosis and unexplained infertility and can be considered, where the duration of infertility is more than four years. A pregnancy rate of around 10% per cycle can be anticipated, but there is a significant risk of multiple pregnancy. The evidence is that IVF (and GIFT) has achieved significantly improved results in recent years, with fecundity rates of 20% per cycle being a reasonable target in women under 40 years.

Entities:  

Mesh:

Year:  1995        PMID: 7490200

Source DB:  PubMed          Journal:  Health Bull (Edinb)        ISSN: 0374-8014


  9 in total

1.  The past, present, and future of embryo selection in in vitro fertilization: Frontiers in Reproduction Conference.

Authors:  Samantha X Y Wang
Journal:  Yale J Biol Med       Date:  2011-12

Review 2.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

3.  Toxic metals signature in the human seminal plasma of Pakistani population and their potential role in male infertility.

Authors:  Ambreen Zafar; Syed Ali Musstjab Akber Shah Eqani; Nazish Bostan; Alessandra Cincinelli; Faheem Tahir; Syed Tahir Abbas Shah; Alamdar Hussain; Ambreen Alamdar; Qingyu Huang; Siyuan Peng; Heqing Shen
Journal:  Environ Geochem Health       Date:  2014-12-04       Impact factor: 4.609

4.  The Association of Appendectomy, Adhesions, Tubal Pathology, and Female Infertility.

Authors:  Victoria Margaux Becker; Saskia Silver; Rudolf Seufert; Oliver J Muensterer
Journal:  JSLS       Date:  2019 Jan-Mar       Impact factor: 2.172

5.  Lead level in seminal plasma may affect semen quality for men without occupational exposure to lead.

Authors:  Hsien-Ming Wu; Dan-Tzu Lin-Tan; Mei-Li Wang; Hong-Yuan Huang; Chyi-Long Lee; Hsin-Shih Wang; Yung-Kuei Soong; Ja-Liang Lin
Journal:  Reprod Biol Endocrinol       Date:  2012-11-08       Impact factor: 5.211

6.  Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial.

Authors:  S Bhattacharya; K Harrild; J Mollison; S Wordsworth; C Tay; A Harrold; D McQueen; H Lyall; L Johnston; J Burrage; S Grossett; H Walton; J Lynch; A Johnstone; S Kini; A Raja; A Templeton
Journal:  BMJ       Date:  2008-08-07

7.  The National Women's Health Study: assembly and description of a population-based reproductive cohort.

Authors:  Noreen Maconochie; Pat Doyle; Susan Prior
Journal:  BMC Public Health       Date:  2004-08-07       Impact factor: 3.295

8.  Speman®, A Proprietary Ayurvedic Formulation, Reverses Cyclophosphamide-Induced Oligospermia In Rats.

Authors:  Mohd Azeemuddin Mukram; Mohamed Rafiq; Suryakant D Anturlikar; Pralhad S Patki
Journal:  Cent Asian J Glob Health       Date:  2013-04-02

9.  The Asprosin-OLFR734 hormonal signaling axis modulates male fertility.

Authors:  Fangchao Wei; Aijun Long; Yiguo Wang
Journal:  Cell Discov       Date:  2019-11-12       Impact factor: 10.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.